MULTIPLE ORAL DOSES (ABT-229)/POSTPRANDIAL DIGESTIVE SYMPTOMS/DYSPEPSIA

功能性或非溃疡性消化不良是一种上消化道疾病。 以持续的或反复出现的上腹部症状为特征 腹部不适，不能归因于结构性或 生化异常。这种疾病在大约25%的人中普遍存在 人口中的一部分。本研究为二期随机双盲试验。 一种新促进剂的安慰剂对照多中心研究 (ABT-229)在非溃疡性消化不良患者中。

Functional or non ulcer dyspepsia is a upper gastrointestinal disorder that is characterized by persistent or recurrent symptoms of upper abdominal discomfort, which cannot be attributed to structural or biochemical abnormalities. The disorder is prevalent in approximately 25% of the population. This study is a phase II randomized double blind placebo-controlled multi center study of a new pro-motility agent (ABT-229) in patients with non ulcer dyspepsia.